Small numbers, big impact

Harvard Review of Psychiatry

Volumn 7, Issue 2, 1999, Pages 109-113

  Smoller, Jordan W ^a   Nierenberg, Andrew A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE;

ARTICLE; DEPRESSION; DRUG APPROVAL; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEIZURE; SUICIDAL BEHAVIOR;

EID: 0032886778     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.1093/hrp/7.2.109     Document Type: Article

References (44)

1. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:207-10.
2. Fava M, Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry 1991;52:108-11.
3. Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991;303:685-92.
4. Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992;268:3441-5.
5. Filteau MJ, Lapierre YD, Bakish D, Blanchard A. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatry Neurosci 1993;18:114-9.
6. Johnston JA, Lineberry CG, Ascher JA, Davidson J, Khayrallah MA, Feighner JP, et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991; 52:450-6.
7. Rosenstein LD, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993;54: 289-99.
8. Sussman N. Bupropion. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Wilkins, 1995:1951-7.
9. Power AC, Cowen PJ. Fluoxetine and suicidal behaviour: some clinical and theoretical aspects of a controversy. Br J Psychiatry 1992;161:735-41.
10. Bernstein PL. Against the gods: the remarkable story of risk. New York: Wiley, 1996.
11. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science 1974;185:1124-31.
12. Kahneman D, Tverksy A. Choices, values, and frames. Am Psychol 1984;39:341-50.
13. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979;47:263-91.
14. Loomes G, Sugden R. Regret theory: an alternative theory of rational choice under uncertainty. Econ J 1982;92:805-24.
15. Sugden R. New developments in the theory of choice under uncertainty. Bull Econ Res 1986;38:1-24.
16. Tversky A, Kahneman D. Belief in the law of small numbers. Psychol Bull 1971;76:105-10.
17. Bryant GD, Norman GR. Expressions of probability: words and numbers [Letter]. N Engl J Med 1980;302:411.
18. Timmermans D. The roles of experience and domain of expertise in using numerical and verbal probability terms in medical decisions. Med Decis Making 1994;14:146-56.
19. Kong A, Barnett GO, Mosteller F, Youtz C. How medical professionals evaluate expressions of probability. N Engl J Med 1986;315:740-4.
20. Merz JF, Druzdzel MJ, Mazur DJ. Verbal expressions of probability in informed consent litigation. Med Decis Making 1991; 11:273-81.
21. Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992;92:121-4.
22. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992;117:916-21.
23. Hux JE, Levinton CM, Naylor CD. Prescribing propensity: influence of life-expectancy gains and drug costs. J Gen Intern Med 1994;9:195-201.
24. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994;309:761-4.
25. Freemantle N. Are decisions taken by health care professionals rational? A non systematic review of experimental and quasi experimental literature. Health Policy 1996;38:71-81.
26. Feinstein AR. The 'chagrin factor' and qualitative decision analysis. Arch Intern Med 1985;145:1257-9.
27. Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicians choose drugs. Soc Sci Med 1988;27:1381-6.
28. Freeman JK, Barnes JH, Summers KH, Szeinbach SL. Modeling physicians' prescribing decisions for patients with panic disorder. J Health Care Marketing 1993;13:34-9.
29. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med 1989;28: 577-82.
30. Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A. Drug expectations and drug choices of hospital physicians. J Intern Med 1993;234:155-63.
31. Lenert LA, Markowitz DR, Blaschke TF. Primum non nocere? Valuing of the risk of drug toxicity in therapeutic decision making. Clin Pharmacol Ther 1993;53:285-91.
32. Armstrong D, Reyburn H, Jones R. A study of general practitioners' reasons for changing their prescribing behaviour. BMJ 1996;312:949-52.
33. Ritov I, Baron J. Outcome knowledge, regret, and omission bias. Org Behav Hum Decis Proc 1995;64:119-27.
34. Denig P, Haaijer-Ruskamp FM. Therapeutic decision making of physicians. Pharm Weekbl 1992;14:9-15.
35. Redelmeier DA, Rozin P, Kahneman D. Understanding patients' decisions: cognitive and emotional perspectives. JAMA 1993;270:72-6.
36. Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA 1995;273:302-5.
37. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992;268:2420-5.
38. McDonald CJ. Medical heuristics: the silent adjudicators of clinical practice. Ann Intern Med 1996;124:56-62.
39. Boissel JP, Ferry S, Gallois P. Use of sales statistics for evaluating prescription rationale. Trends Pharmacol Sci 1983;October:401-4.
40. Raisch DW. A model of methods for influencing prescribing, part II: A review of educational methods, theories of human inference, and delineation of the model. Ann Pharmacother 1990;24:537-42.
41. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4-8.
42. Griffin D, Tversky A. The weighing of evidence and the determinants of confidence. Cogn Psychol 1992;24:411-35.
43. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence: a report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970;25:745-57.
44. Shorter E. A history of psychiatry: from the era of the asylum to the age of Prozac. New York: Wiley, 1997.